Coronavirus pandemic | Y Combinator hunkers down, may work remotely for next batch  

The announcement is a blow to startups, as the US-based seed accelerator has increased its focus on India.

March 16, 2020 / 12:51 IST
Story continues below Advertisement

Startup accelerator Y Combinator, an early backer of firms such as Airbnb, Dropbox and Reddit, said on March 16 its Summer 2020 batch could be held remotely due to the coronavirus outbreak that has now spread to more than 110 countries.

Silicon Valley-based Y Combinator, known as YC, has a program for aspiring entrepreneurs, providing them mentorship and investment. The two to three-month program allows founders to interact among themselves and with industry experts. It culminates in YC Demo Day, where selected companies pitch their products to potential investors.

Story continues below Advertisement

“Like every organization, we’ve been weighing how to respond and have already announced that W20 Demo Day will be a week early and online only... Additionally, depending on the circumstances this summer, some or all of the batches may take place remotely over the video,” Y-Combinator said in a blog post.

 YC is seen as the world’s marquee incubator of startups and it has ramped up its India focus. For its winter 2019 batch, YC picked a record 28 Indian startups, more than double the 12 firms it previously picked.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show